| DIRECT COMPETITOR COMPARISON | |
| POZN | AZN | ENDP | GSK | Industry | | Market Cap: | 212.95M | 66.29B | 2.65B | 107.61B | 161.24M | | Employees: | 34 | 65,000 | 1,216 | 99,003 | 103 | | Qtrly Rev Growth (yoy): | 28.20% | 5.50% | 14.00% | 14.90% | 20.50% | | Revenue (ttm): | 42.00M | 32.05B | 1.42B | 44.80B | 46.74M | | Gross Margin (ttm): | 23.41% | 82.24% | 75.15% | 76.27% | 68.58% | | EBITDA (ttm): | -6.03M | 13.52B | 461.38M | 17.66B | -7.12M | | Oper Margins (ttm): | -14.42% | 37.85% | 27.58% | 34.30% | 2.25% | | Net Income (ttm): | -5.16M | 7.22B | 197.58M | 8.05B | N/A | | EPS (ttm): | -0.173 | 4.98 | 1.685 | 3.15 | -0.17 | | P/E (ttm): | N/A | 9.18 | 13.42 | 13.48 | 17.12 | | PEG (5 yr expected): | N/A | N/A | 0.84 | 3.06 | 1.04 | | P/S (ttm): | 5.01 | 2.03 | 1.82 | 2.35 | 4.17 |
|
| AZN = AstraZeneca plc | | ENDP = Endo Pharmaceuticals Holdings Inc. | | GSK = GlaxoSmithKline plc | | Industry = Drug Manufacturers - Other | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.0128 | 1.18% | 57.70B | 12.43 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.82 | 1.87% | 13.83B | 16.00 | | Genzyme Corp. | GENZ | 51.37 | 1.32% | 13.63B | 29.29 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.22 | 0.24% | 41.59B | 17.87 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.905 | 2.26% | 9.08B | 1038.88 | | Teva Pharmaceutical Industries Limited | TEVA | 53.60 | 1.53% | 47.22B | 49.04 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.56 | 1.27% | 3.99B | 19.36 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.89 | 0.51% | 2.95B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.20 | 1.85% | 5.56B | 111.66 | | Pfizer Inc. | PFE | 18.765 | 3.27% | 151.42B | 15.59 | | Johnson & Johnson | JNJ | 63.39 | 0.88% | 174.90B | 13.84 | | GlaxoSmithKline plc | GSK | 42.45 | 2.36% | 107.61B | 13.48 | | Sanofi-Aventis | SNY | 39.34 | 3.64% | 102.72B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 56.26 | 1.19% | 127.78B | 16.84 | | RHHBY.PK | 41.38 | 1.12% | N/A | N/A | | AstraZeneca plc | AZN | 45.72 | 1.99% | 66.29B | 9.18 | | Abbott Laboratories | ABT | 54.59 | 0.18% | 84.44B | 14.79 | | Bristol-Myers Squibb Co. | BMY | 24.934999 | -1.48% | 49.40B | 12.90 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | ENDP | | December's Defensive Game Plan for Biotech
Tue 10:06am -
at Seeking Alpha | | • | GSK | | 5-Star Stocks Poised to Pop: Abbott Labs
Tue 9:30am -
at Motley Fool | | • | AZN | | AstraZeneca's Latest Cost-Cutting Move: Offshore Production
Tue 9:11am -
at Seeking Alpha | | • | GSK | | Immunogen's Busy Month, Part I
Tue 8:51am -
at Seeking Alpha | | • | GSK | | WHO approves Glaxo's swine flu shot
Tue 6:19am -
AP | | • | GSK | | Glaxo takes 19 percent stake in Aspen
Tue 5:35am -
AP | | • | GSK | | Human Genome Sciences to sell up to 12.5M shares
Mon 5:01pm -
AP | | • | GSK | | Making Money More Efficiently
Mon 3:25pm -
at Motley Fool | | • | AZN | | Health Care Company Acquisition Price By Private Equity 22% Over Predicted Price By Small Cap Expert
Mon 1:41pm -
Wall Street Transcript | | • | AZN | | 8 HealthCare Stocks With 3%+ Dividends
Sun, Nov 29 -
at Seeking Alpha | | • | AZN | | Biotech Stocks: Dubai jitters rattle drug stocks; QLT gains
Fri, Nov 27 -
at MarketWatch | | • | AZN | | A Mostly Meaningless FDA Approval
Fri, Nov 27 -
at Motley Fool | | • | AZN | | Zacks #1 Rank Additions for Friday
Fri, Nov 27 -
Zacks.com | | • | ENDP | | Prospecting for Stocks: Novartis
Wed, Nov 25 -
at Motley Fool | | • | ENDP | | 12 Companies With Ironclad Balance Sheets
Wed, Nov 25 -
at Motley Fool | | • | AZN | | The Group Behind The Mammogram Guidelines
Wed, Nov 25 -
at Forbes.com | | • | AZN | | Novartis opens new flu vaccine plant in US
Tue, Nov 24 -
at Reuters | | • | ENDP | | Which Drug Companies Could Be Private-Equity Targets?
Mon, Nov 23 -
at The Wall Street Journal Online | | • | ENDP | | ENDO PHARMACEUTICALS HOLDINGS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Fri, Nov 13 -
EDGAR Online | | • | ENDP | | Endo paying $23M to settle patent dispute with LecTec
Thu, Nov 12 -
at bizjournals.com | | • | ENDP | | UPDATE - Endo and LecTec settle patent dispute
Wed, Nov 11 -
at Reuters | | | All Headlines for these symbols... |
|
|
|
1.19% Nasdaq 
Competitors
